您当前的位置:牛牛财经 > 股票

丽珠医药(01513)抗癌药注射用醋酸亮丙瑞林微球获准开展临床试验

2019-03-17     牛牛财经   来源:
文章摘要:智通财经APP讯,丽珠医药(01513)公告,公司控股子公司上海丽珠制药有限公司(简称“上海丽珠”)收到国家药品监督管理局(简称“药监局”)核准签发的《临床试验通知书》。药物名称:注射用醋酸亮丙瑞林微球。审批结论:根据《中华人民共和国药品管理法》及有关规定….

zhitongcaijingAPP讯xun,丽lizhuyiyao(01513)公gonggao,公gongsikongguzigongsishanghailizhuzhiyaoyouxiangongsi(简jiancheng“上shanghailizhu”)收shoudaoguojiayaopinjianduguanliju(简jiancheng“药yaojianju”)核hezhunqianfade《临linchuangshiyantongzhishu》。药yaowumingcheng:注zhusheyongcusuanliangbingruilinweiqiu。审shenpijielun:根genju《中zhonghuarenmingongheguoyaopinguanlifa》及jiyouguanguiding,经jingshencha,2018年nian08月yue01日rishoulidezhusheyongcusuanliangbingruilinweiqiufuheyaopinzhucedeyouguanyaoqiu,同tongyikaizhanlinchuangshiyan

“注zhusheyongcusuanliangbingruilinweiqiu(11.25mg)”历lijing4年nianyanfa,申shenbaoshengchandeshenqingyiyu2018年nian08月yue01日rihuodeshouli(受shoulihao:CYHS1800206)。“注zhusheyongcusuanliangbingruilinweiqiu(11.25mg)”是shicusuanliangbingruilindechangxiaohuanshizhiji,和heyuanyanyaoyinatong(11.25mg)具juyouxiangtongdezuoyongjizhi,每mei12周zhougeiyao1次ci,大dafujiangdigeiyaopinlv,降jiangdiliaoyaowudufufanying,改gaishanliaohuanzheyongyaodeyicongxing,其qizhuyaoyongyuzhiliaoqianliexianaihejuejingqianruxianai

jiezhigonggaopiluri,“注zhusheyongcusuanliangbingruilinweiqiu(11.25mg)”已yileijitouruyanfafeiyongyueweirenminbi1687.04万wanyuan


收集整理:牛牛财经网
本文地址:https://stock.nncj.com/a/6848
共有条评论发表评论
验证码:
推荐阅读